NO900830D0 - Fremgangsmaate for fremstilling av piperidinforbindelser. - Google Patents
Fremgangsmaate for fremstilling av piperidinforbindelser.Info
- Publication number
- NO900830D0 NO900830D0 NO900830A NO900830A NO900830D0 NO 900830 D0 NO900830 D0 NO 900830D0 NO 900830 A NO900830 A NO 900830A NO 900830 A NO900830 A NO 900830A NO 900830 D0 NO900830 D0 NO 900830D0
- Authority
- NO
- Norway
- Prior art keywords
- piperide
- compounds
- procedure
- preparation
- piperide compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK82589A DK82589A (da) | 1989-02-22 | 1989-02-22 | Piperidinforbindelser, deres fremstilling og anvendelse |
DK231589A DK231589D0 (da) | 1989-05-12 | 1989-05-12 | Piperidinforbindelser og deres fremstilling og anvendelse |
Publications (4)
Publication Number | Publication Date |
---|---|
NO900830D0 true NO900830D0 (no) | 1990-02-21 |
NO900830L NO900830L (no) | 1990-08-23 |
NO179639B NO179639B (no) | 1996-08-12 |
NO179639C NO179639C (no) | 1996-11-20 |
Family
ID=26064725
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO900830A NO179639C (no) | 1989-02-22 | 1990-02-21 | Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte piperidinforbindelser |
NO90900831A NO900831L (no) | 1989-02-22 | 1990-02-21 | Fremgangsmaate for fremstilling av piperidinforbindelser. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO90900831A NO900831L (no) | 1989-02-22 | 1990-02-21 | Fremgangsmaate for fremstilling av piperidinforbindelser. |
Country Status (22)
Country | Link |
---|---|
US (5) | US5043345A (no) |
EP (2) | EP0384285A3 (no) |
JP (2) | JP2921578B2 (no) |
KR (1) | KR0163763B1 (no) |
CN (1) | CN1028105C (no) |
AR (1) | AR247565A1 (no) |
AT (1) | ATE123030T1 (no) |
AU (2) | AU629302B2 (no) |
CA (2) | CA2010579A1 (no) |
DE (1) | DE69019550T2 (no) |
DK (1) | DK0384288T3 (no) |
ES (1) | ES2072323T3 (no) |
FI (2) | FI900887A0 (no) |
GR (1) | GR3017062T3 (no) |
HU (2) | HU221623B1 (no) |
IE (1) | IE69672B1 (no) |
IL (2) | IL93352A (no) |
NO (2) | NO179639C (no) |
NZ (1) | NZ232615A (no) |
PH (1) | PH26465A (no) |
PT (2) | PT93241B (no) |
RU (1) | RU2042676C1 (no) |
Families Citing this family (90)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0372125A1 (en) * | 1988-11-08 | 1990-06-13 | Akzo N.V. | Oxazole and thiazole derivatives |
US5328925A (en) * | 1989-02-22 | 1994-07-12 | Novo Nordisk A/S | Piperidine compounds and their use |
US5264444A (en) * | 1989-02-22 | 1993-11-23 | Novo Nordisk A/S | Piperidine compounds and use |
US5043345A (en) * | 1989-02-22 | 1991-08-27 | Novo Nordisk A/S | Piperidine compounds and their preparation and use |
US5260311A (en) * | 1989-02-22 | 1993-11-09 | Novo Nordisk A/S | Piperidine compounds and their use |
EP0459568A3 (en) * | 1990-05-31 | 1992-09-30 | Merck Sharp & Dohme Ltd. | Substituted oxadiazoles and thiadiazoles for use in the treatment of glaucoma and novel compounds having such use |
US5376668A (en) * | 1990-08-21 | 1994-12-27 | Novo Nordisk A/S | Heterocyclic compounds |
DK198490D0 (da) * | 1990-08-21 | 1990-08-21 | Novo Nordisk As | Heterocykliske forbindelser, deres fremstilling og anvendelse |
US5418240A (en) * | 1990-08-21 | 1995-05-23 | Novo Nordisk A/S | Heterocyclic compounds and their preparation and use |
DK198390D0 (da) * | 1990-08-21 | 1990-08-21 | Novo Nordisk As | Heterocykliske forbindelser, deres fremstilling og anvendelse |
USRE35822E (en) * | 1990-08-21 | 1998-06-09 | Novo Nordisk A/S | Heterocyclic compounds |
US5527813A (en) * | 1990-08-21 | 1996-06-18 | Novo Nordisk A/S | Heterocyclic compounds and their preparation and use |
DK198590D0 (da) * | 1990-08-21 | 1990-08-21 | Novo Nordisk As | Heterocykliske forbindelser, deres fremstilling og anvendelse |
AU656547B2 (en) * | 1990-11-29 | 1995-02-09 | Allergan, Inc. | Use of pyridine derivatives in the treatment of ocular hypertension |
EP0492903A1 (en) * | 1990-12-21 | 1992-07-01 | MERCK SHARP & DOHME LTD. | Substituted pyrazines, pyrimidines and pyridazines for use in the treatment of glaucoma |
IE922270A1 (en) * | 1991-07-26 | 1993-01-27 | Akzo Nv | Pyrazole derivatives |
US5641791A (en) * | 1991-08-13 | 1997-06-24 | Novo Nordisk A.S | Heterocyclic compounds and their preparation and use |
US5175166A (en) * | 1991-08-27 | 1992-12-29 | The University Of Toledo | Muscarinic agonists |
WO1993014089A1 (en) * | 1992-01-13 | 1993-07-22 | Novo Nordisk A/S | Heterocyclic compounds and their preparation and use |
US5244906A (en) * | 1992-01-23 | 1993-09-14 | Dowelanco | Insect control with substituted oxadiazole and thiadiazole compounds |
ATE182139T1 (de) * | 1992-10-23 | 1999-07-15 | Merck Sharp & Dohme | Dopamin rezeptor subtyp liganden |
DK0703915T3 (da) * | 1993-06-04 | 2001-01-22 | Novo Nordisk As | Hetrocyklisk kemi |
US5753683A (en) * | 1993-08-19 | 1998-05-19 | Novo Nordisk A/S | Antipsychotic method |
CZ285030B6 (cs) * | 1993-08-19 | 1999-05-12 | Novo Nordisk A/S | Použití thiadiazolových a oxadiazolových sloučenin pro výrobu farmaceutického prostředku a farmacetický prostředek pro léčení schizofrenie nebo schizofrenních nemocí |
US5545638A (en) * | 1993-12-21 | 1996-08-13 | Novo Nordisk A/S | Method of treating gastrointestinal motility disorders |
IL112024A (en) * | 1993-12-21 | 1999-07-14 | Novo Nordisk As | Pharmaceutical compositions comprising tetrahydropyridine derivatives substituted with oxadiazole or thiadiazole for treating gastrointestinal motility disorders |
US5605908A (en) * | 1994-10-24 | 1997-02-25 | Eli Lilly And Company | Heterocyclic compounds and their use |
US5998404A (en) | 1994-10-24 | 1999-12-07 | Eli Lilly And Company | Heterocyclic compounds and their use |
US5821370A (en) * | 1994-10-24 | 1998-10-13 | Eli Lilly And Company | Heterocyclic compounds and their preparation and use |
US5726193A (en) * | 1994-10-31 | 1998-03-10 | Eli Lilly And Company | Method for treating anxiety |
US5574028A (en) * | 1994-10-31 | 1996-11-12 | Eli Lilly And Company | Method for treating anxiety |
US5488056A (en) * | 1994-10-31 | 1996-01-30 | Eli Lilly And Company | Method for treating anxiety |
US5484794A (en) * | 1994-11-09 | 1996-01-16 | Eli Lilly And Company | Method for treating anxiety |
EP0709094B1 (en) * | 1994-10-31 | 2000-04-05 | Eli Lilly And Company | Tetrahydropyridine oxadiazole or thiadiazole compound for treating anxiety |
US5612351A (en) * | 1994-11-08 | 1997-03-18 | Novo Nordisk A/S | Method of treating urinary bladder dysfunctions |
US5565475A (en) * | 1994-11-08 | 1996-10-15 | Muhlhauser; Mark A. | Method of treating urinary bladder dysfunctions with 3-tetrahydropyridine derivatives |
TW304167B (no) * | 1995-01-30 | 1997-05-01 | Lilly Co Eli | |
US5605701A (en) * | 1995-02-17 | 1997-02-25 | Eli Lilly And Company | Transdermal formulation |
US5763457A (en) * | 1995-11-13 | 1998-06-09 | Eli Lilly And Company | Method for treating anxiety |
US5852037A (en) | 1995-11-13 | 1998-12-22 | Eli Lilly And Company | Method for treating anxiety |
WO1997020819A1 (en) * | 1995-12-06 | 1997-06-12 | Eli Lilly And Company | Composition for treating pain |
EP0866702A4 (en) * | 1995-12-07 | 2001-07-25 | Lilly Co Eli | METHOD OF TREATMENT |
GB9603755D0 (en) * | 1996-02-22 | 1996-04-24 | Pfizer Ltd | Therapeutic agents |
AU2991397A (en) * | 1996-04-23 | 1997-11-12 | Eli Lilly And Company | Heterocyclic compounds |
EP0912183A4 (en) * | 1996-04-23 | 1999-08-04 | Lilly Co Eli | HETEROCYCLIC COMPOSITIONS |
JP2000513712A (ja) * | 1996-04-24 | 2000-10-17 | ノボ ノルディスク アクティーゼルスカブ | 複素環化合物およびその調製およびその使用 |
EP0821958A3 (en) * | 1996-08-01 | 1998-07-08 | Eli Lilly And Company | Use of 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine (xanomeline) for treating excessive aggression |
US6090829A (en) * | 1996-08-01 | 2000-07-18 | Eli Lilly And Company | Method for treating excessive aggression |
ES2171838T3 (es) * | 1996-08-01 | 2002-09-16 | Lilly Co Eli | Uso de 3-(4-hexiloxi-1,2,5-tiadiazol-3-il)-1,2,5,6-tetrahidro-1-metilpiridina (xanomelina) para el tratamiento del trastorno bipolar. |
EP0821956A1 (en) * | 1996-08-01 | 1998-02-04 | Eli Lilly And Company | Method for treating disruptive behavior disorders |
EP0821954A1 (en) * | 1996-08-01 | 1998-02-04 | Eli Lilly And Company | Method for treating mental retardation |
EP0821957A3 (en) * | 1996-08-01 | 1998-04-22 | Eli Lilly And Company | Use of 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine (xanomeline) for treating substance abuse |
US6117890A (en) * | 1996-08-01 | 2000-09-12 | Eli Lilly And Company | Method for treating bipolar disorder |
US6043258A (en) * | 1996-08-01 | 2000-03-28 | Eli Lilly And Company | Method for treating disruptive behavior disorders with xanomeline |
EP0821959A3 (en) * | 1996-08-01 | 1998-09-16 | Eli Lilly And Company | Use of 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine for treating nicotine withdrawal |
EP0934040A1 (en) * | 1996-10-23 | 1999-08-11 | Eli Lilly And Company | Method for treating dementia due to aids |
US6297262B1 (en) | 1997-05-29 | 2001-10-02 | H. Lundbeck A/S | Treatment of schizophrenia and psychosis |
US6034108A (en) * | 1997-07-28 | 2000-03-07 | Eli Lilly And Company | Method for treating mental retardation |
US6528529B1 (en) | 1998-03-31 | 2003-03-04 | Acadia Pharmaceuticals Inc. | Compounds with activity on muscarinic receptors |
US6096767A (en) * | 1999-01-22 | 2000-08-01 | The University Of Toledo | Muscarinic receptor agonists |
US6211204B1 (en) | 1999-01-22 | 2001-04-03 | University Of Toledo | Muscarinic receptor agonists |
US6376675B2 (en) | 1999-01-22 | 2002-04-23 | The University Of Toledo | Muscarinic receptor agonists |
US20040023951A1 (en) * | 2001-06-18 | 2004-02-05 | Bymaster Franklin Porter | Combination therapy for treatment of psychoses |
WO2007025177A2 (en) * | 2005-08-26 | 2007-03-01 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
CN1821243B (zh) * | 2005-08-30 | 2010-12-08 | 北京大学 | 取代的吡啶类m1受体激动剂、其制备方法及其用途 |
WO2007047978A2 (en) | 2005-10-21 | 2007-04-26 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
US20070112017A1 (en) | 2005-10-31 | 2007-05-17 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
EP1973904A2 (en) * | 2005-12-27 | 2008-10-01 | University Of Toledo | Muscarinic agonists and methods of use thereof |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
EP2026813A2 (en) | 2006-05-09 | 2009-02-25 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
JP2009536669A (ja) | 2006-05-09 | 2009-10-15 | ブレインセルス,インコーポレイティド | アンジオテンシン調節による神経新生 |
BRPI0716604A2 (pt) | 2006-09-08 | 2013-04-09 | Braincells Inc | combinaÇÕes contendo um derivado de 4-acilaminopiridina |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
US20110294835A1 (en) | 2008-05-15 | 2011-12-01 | The Board Of Trustees Of The University Of Illinois | Muscarinic Agonists as Cognitive Enhancers |
WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
WO2011011060A1 (en) | 2009-07-22 | 2011-01-27 | Puretech Ventures | Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation |
US10265311B2 (en) | 2009-07-22 | 2019-04-23 | PureTech Health LLC | Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation |
JP5916746B2 (ja) | 2010-11-15 | 2016-05-11 | エージンバイオ, インコーポレイテッド | 認知障害を処置するためのピリダジン誘導体、組成物、および方法 |
WO2012149524A1 (en) | 2011-04-29 | 2012-11-01 | The University Of Toledo | Muscarinic agonists as enhancers of working memory and cognitive flexibility |
CA2934553C (en) | 2013-12-20 | 2023-10-31 | Agenebio, Inc. | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment |
IL256354B (en) | 2015-06-19 | 2022-09-01 | Agenebio Inc | History of benzodiazepines, preparations and their use for the treatment of cognitive impairment |
EP3347011A4 (en) | 2015-09-11 | 2019-06-19 | Chase Pharmaceuticals Corporation | MUSCARIN COMBINATION AND ITS USE FOR COMBATING HYPOCHOLINERGEN DISORDERS OF THE CENTRAL NERVOUS SYSTEM |
US20180170941A1 (en) | 2016-12-19 | 2018-06-21 | Agenebio, Inc. | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment |
US11505555B2 (en) | 2016-12-19 | 2022-11-22 | Agenebio, Inc. | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment |
BR112020026062B1 (pt) | 2018-06-19 | 2023-04-04 | Agenebio, Inc | Compostos derivados de benzodiazepina ou um sal farmaceuticamente aceitavel, isômero ou combinação dos mesmos, composição farmacêutica compreendendo os mesmos e usos dos mesmos para o tratamento de comprometimento cognitivo, câncer cerebral e psicose da doença de parkinson |
KR102408292B1 (ko) | 2018-09-28 | 2022-06-10 | 카루나 세러퓨틱스 인코포레이티드 | 무스카린성 수용체 활성화에 의해 개선된 장애의 치료를 위한 조성물 및 방법 |
US11534434B2 (en) | 2019-11-15 | 2022-12-27 | Karuna Therapeutics, Inc. | Xanomeline derivatives and methods for treating neurological disorders |
CN115974863A (zh) * | 2021-10-14 | 2023-04-18 | 南京迈诺威医药科技有限公司 | 占诺美林衍生物的苹果酸盐、a晶型及其制备方法和用途 |
WO2024039886A1 (en) | 2022-08-19 | 2024-02-22 | Agenebio, Inc. | Benzazepine derivatives, compositions, and methods for treating cognitive impairment |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ219646A (en) * | 1986-03-27 | 1990-10-26 | Merck Sharp & Dohme | Oxadiazole derivatives of azacyclics for treating cns disorders |
IL83275A (en) * | 1986-09-08 | 1994-02-27 | Novo Nordisk As | Compounds 1,2, 4-Oxadiazolyl Pipridine Transformed, their preparation and pharmaceutical preparations containing them |
US5017618A (en) * | 1987-03-16 | 1991-05-21 | University Of Florida | Labile derivatives of ketone analogs of 3-substituted-1-alkylamino-2-propanols and their use as beta-adrenergic blockers |
GB8714789D0 (en) * | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
NZ225999A (en) * | 1987-09-10 | 1992-04-28 | Merck Sharp & Dohme | Azacyclic- or azabicyclic-substituted thiadiazole derivatives and pharmaceutical compositions |
IL88156A (en) * | 1987-11-13 | 1997-02-18 | Novo Nordisk As | Azacyclic compounds their preparation and pharmaceutical compositions containing them |
NZ227841A (en) * | 1988-02-12 | 1991-08-27 | Merck Sharp & Dohme | Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions |
DK162892C (da) * | 1988-07-04 | 1992-05-11 | Novo Nordisk As | 1,2,5,6-tetrahydropyridinforbindelser, deres fremstilling og farmaceutiske praeparater indeholdende disse |
US5043345A (en) * | 1989-02-22 | 1991-08-27 | Novo Nordisk A/S | Piperidine compounds and their preparation and use |
US5260311A (en) * | 1989-02-22 | 1993-11-09 | Novo Nordisk A/S | Piperidine compounds and their use |
US5328925A (en) * | 1989-02-22 | 1994-07-12 | Novo Nordisk A/S | Piperidine compounds and their use |
US5264444A (en) * | 1989-02-22 | 1993-11-23 | Novo Nordisk A/S | Piperidine compounds and use |
DK198390D0 (da) * | 1990-08-21 | 1990-08-21 | Novo Nordisk As | Heterocykliske forbindelser, deres fremstilling og anvendelse |
DK198490D0 (da) * | 1990-08-21 | 1990-08-21 | Novo Nordisk As | Heterocykliske forbindelser, deres fremstilling og anvendelse |
US5175166A (en) * | 1991-08-27 | 1992-12-29 | The University Of Toledo | Muscarinic agonists |
-
1989
- 1989-08-31 US US07/401,370 patent/US5043345A/en not_active Expired - Lifetime
-
1990
- 1990-02-12 IL IL9335290A patent/IL93352A/en not_active IP Right Cessation
- 1990-02-13 IE IE50490A patent/IE69672B1/en not_active IP Right Cessation
- 1990-02-14 ES ES90102913T patent/ES2072323T3/es not_active Expired - Lifetime
- 1990-02-14 PH PH40049A patent/PH26465A/en unknown
- 1990-02-14 EP EP19900102889 patent/EP0384285A3/en not_active Withdrawn
- 1990-02-14 EP EP90102913A patent/EP0384288B1/en not_active Expired - Lifetime
- 1990-02-14 DK DK90102913.2T patent/DK0384288T3/da active
- 1990-02-14 AT AT90102913T patent/ATE123030T1/de not_active IP Right Cessation
- 1990-02-14 DE DE69019550T patent/DE69019550T2/de not_active Expired - Fee Related
- 1990-02-16 IL IL93423A patent/IL93423A0/xx unknown
- 1990-02-20 AU AU49997/90A patent/AU629302B2/en not_active Ceased
- 1990-02-20 US US07/482,272 patent/US5041455A/en not_active Expired - Lifetime
- 1990-02-20 AU AU49996/90A patent/AU4999690A/en not_active Abandoned
- 1990-02-20 NZ NZ232615A patent/NZ232615A/en unknown
- 1990-02-21 CA CA002010579A patent/CA2010579A1/en not_active Abandoned
- 1990-02-21 RU SU904743296A patent/RU2042676C1/ru not_active IP Right Cessation
- 1990-02-21 KR KR1019900002108A patent/KR0163763B1/ko not_active IP Right Cessation
- 1990-02-21 NO NO900830A patent/NO179639C/no not_active IP Right Cessation
- 1990-02-21 AR AR90316209A patent/AR247565A1/es active
- 1990-02-21 HU HU9000884A patent/HU221623B1/hu not_active IP Right Cessation
- 1990-02-21 NO NO90900831A patent/NO900831L/no unknown
- 1990-02-21 CA CA002010578A patent/CA2010578C/en not_active Expired - Lifetime
- 1990-02-22 FI FI900887A patent/FI900887A0/fi not_active Application Discontinuation
- 1990-02-22 FI FI900886A patent/FI95704C/fi active IP Right Grant
- 1990-02-22 JP JP2039899A patent/JP2921578B2/ja not_active Expired - Fee Related
- 1990-02-22 JP JP2039900A patent/JPH02255680A/ja active Pending
- 1990-02-22 PT PT93241A patent/PT93241B/pt not_active IP Right Cessation
- 1990-02-22 PT PT93242A patent/PT93242A/pt not_active Application Discontinuation
- 1990-02-22 CN CN90100873A patent/CN1028105C/zh not_active Expired - Fee Related
-
1991
- 1991-08-15 US US07/745,568 patent/US5284859A/en not_active Expired - Lifetime
-
1995
- 1995-06-07 US US08/472,356 patent/US5559138A/en not_active Expired - Lifetime
- 1995-06-29 HU HU95P/P00607P patent/HU211705A9/hu unknown
- 1995-08-09 GR GR950402188T patent/GR3017062T3/el unknown
-
1996
- 1996-09-23 US US08/717,647 patent/US5712297A/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO900830L (no) | Fremgangsmaate for fremstilling av piperidinforbindelser. | |
NO904987L (no) | Fremgangsmaate for fremstilling av indolderivater. | |
NO905008D0 (no) | Fremgangsmaate for fremstilling av heterocykliske forbindelser. | |
NO902003D0 (no) | Fremgangsmaate for fremstilling av n-heteroaryl-4-quinolinaminer. | |
NO901554L (no) | Fremgangsmaate for fremstilling av dinatrium-cefodizim. | |
NO904285L (no) | Fremgangsmaate for fremstilling av substituerte karboksytetrahydroisokinoliner. | |
NO903431L (no) | Fremgangsmaate for fremstilling av kromanderivater. | |
NO892204D0 (no) | Fremgangsmaate for fremstilling av imidazokinoxalin-forbindelser. | |
NO903275D0 (no) | Fremgangsmaate for fremstilling av kromanderivater. | |
NO905377L (no) | Fremgangsmaate for fremstilling av glycerolderivater. | |
NO903043L (no) | Fremgangsmaate for fremstilling av kromanderivater. | |
NO903207L (no) | Fremgangsmaate for fremstilling av halogenaminoaromatiske derivater. | |
NO913692L (no) | Fremgangsmaate for fremstilling av karbapenemforbindelser. | |
NO903666D0 (no) | Fremgangsmaate for fremstilling av pyrrolokinolinforbindelser. | |
NO901067L (no) | Fremgangsmaate for fremstilling av tiofener. | |
NO902762D0 (no) | Fremgangsmaate for fremstilling av 5-fenyl-2-furan derivater. | |
NO904535L (no) | Fremgangsmaate for fremstilling av fenoksy-heterocykliske forbindelser. | |
NO904060L (no) | Fremgangsmaate for fremstilling av substituerte dibenzofuraner. | |
NO900969L (no) | Fremgangsmaate for fremstilling av n-allymetatrifluormetylanilin. | |
NO905047L (no) | Fremgangsmaate for fremstilling av selenofenderivater. | |
NO904070L (no) | Fremgangsmaate for fremstilling av alkanfenoner. | |
NO890538L (no) | Fremgangsmaate for fremstilling av oxadiazolyl-azabicyclo-heptaner. | |
NO920207D0 (no) | Fremgangsmaate for fremstilling av 6-methyl-oestra-4,6-diener | |
NO913089D0 (no) | Fremgangsmaate for fremstilling av tetrazolforbindelser. | |
NO904362D0 (no) | Fremgangsmaate for fremstilling av kromanderivater. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |